Skip to content

13F-HR filed by a16z Capital Management, L.L.C.

a16z Capital Management, L.L.C. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 10 holding rows worth $312,909,254.

Accession
0001415889-25-021833
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 10 entries on the cover page, a total value of $312,909,254 stated on the cover page (in dollars after the unit check, H1), rows summing to $312,909,254 with VALUE read as dollars as filed, 13F file number 028-23922. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock2,748,523$101,118,161dollars as filed
OMADA HEALTH INC68170A108COM4,614,574$84,446,704dollars as filed
BLOCK INC CL A852234103Stock1,016,697$69,064,227dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock1,702,225$20,886,301dollars as filed
BIOAGE LABS INC COM09077V100Stock3,233,170$13,352,992dollars as filed
NAUTILUS BIOTECHNOLOGY INC63909J108COM17,653,917$12,797,324dollars as filed
ERASCA INC COM29479A108Stock2,862,500$3,635,375dollars as filed
OPENDOOR TECHNOLOGIES INC683712103COM6,200,821$3,305,038dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM2,125,339$3,081,742dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X209COMMON STOCK108,568$1,221,390dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-25-021833this filing2025-08-14acceptance time not in the bulk data set